Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last SFr.113.40 CHF
Change Today +0.80 / 0.71%
Volume 389.6K
As of 12:43 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Elias Adam Zerhouni M.D.

President of Global Research & Development of Sanofi, Actelion Ltd.
AgeTotal Calculated CompensationThis person is connected to 103 board members in 6 different organizations across 6 different industries.

See Board Relationships


Dr. Elias Adam Zerhouni, M.D has been the President of Global Research and Development at Sanofi since January 2011. Dr. Zerhouni serves as a Consultant. He serves as Senior Advisor of Johns Hopkins University School of Medicine. He served as Managing Director and President of Global R&D Medicines & Vaccines of Sanofi-aventis (now Sanof). He served as a Principal Investigator on three NIH grants and Co-investigator on two others. He served as a Consultant to the World ...

Read Full Background

Corporate Headquarters*

Gewerberstrasse 16
Allschwil, Basel-Landschaft 4123


Phone: 41 61 565 65 65
Fax: 41 61 565 65 00

Board Members Memberships*

Emeritus Public Trustee
Member of Board of Trustees
Former Director
President of Global Research & Development of Sanofi
Director and Member of Nominating & Governance Committee


Bachelor's Degree 1975
University Of Algiers

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATLN:VX SFr.113.40 CHF +0.80


Marc M.P. de Garidel Chairman, Chief Executive Officer and Member of Strategic Committee
Ipsen S.A.
Giovanni Recordati Chairman, Chief Executive Officer and General Manager
Recordati SpA
Jean-Christophe Tellier Chief Executive Officer and Executive Director
Jörg-Thomas Dierks Chief Executive Officer
Meda AB
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACTELION LTD-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at